FIL Ltd Has $17.37 Million Stock Position in Encompass Health Co. (NYSE:EHC)

FIL Ltd lifted its position in shares of Encompass Health Co. (NYSE:EHC - Free Report) by 4.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 188,107 shares of the company's stock after buying an additional 8,116 shares during the period. FIL Ltd owned about 0.19% of Encompass Health worth $17,372,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of EHC. MassMutual Private Wealth & Trust FSB boosted its position in Encompass Health by 87.8% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company's stock worth $27,000 after acquiring an additional 137 shares during the last quarter. CBIZ Investment Advisory Services LLC lifted its position in shares of Encompass Health by 38.7% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company's stock worth $42,000 after purchasing an additional 127 shares in the last quarter. Tompkins Financial Corp acquired a new position in Encompass Health during the fourth quarter worth $46,000. V Square Quantitative Management LLC grew its position in Encompass Health by 43.8% in the fourth quarter. V Square Quantitative Management LLC now owns 581 shares of the company's stock valued at $54,000 after purchasing an additional 177 shares in the last quarter. Finally, Signaturefd LLC lifted its position in Encompass Health by 21.6% during the 4th quarter. Signaturefd LLC now owns 704 shares of the company's stock worth $65,000 after buying an additional 125 shares in the last quarter. 97.25% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Encompass Health

In related news, CAO Andrew L. Price sold 5,042 shares of the company's stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $98.29, for a total value of $495,578.18. Following the transaction, the chief accounting officer now directly owns 69,164 shares in the company, valued at approximately $6,798,129.56. This represents a 6.79 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 2.10% of the company's stock.

Remove Ads

Encompass Health Stock Performance

Shares of EHC traded down $0.96 during trading hours on Tuesday, hitting $102.30. The company had a trading volume of 775,382 shares, compared to its average volume of 662,251. The business has a fifty day moving average of $99.59 and a 200-day moving average of $98.08. The company has a quick ratio of 1.04, a current ratio of 1.05 and a debt-to-equity ratio of 0.84. The firm has a market cap of $10.30 billion, a price-to-earnings ratio of 22.94, a PEG ratio of 2.31 and a beta of 0.87. Encompass Health Co. has a 12 month low of $78.53 and a 12 month high of $105.23.

Encompass Health (NYSE:EHC - Get Free Report) last released its quarterly earnings results on Thursday, February 6th. The company reported $1.17 earnings per share for the quarter, beating the consensus estimate of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. Equities analysts anticipate that Encompass Health Co. will post 4.8 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be paid a $0.17 dividend. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $0.68 annualized dividend and a yield of 0.66%. Encompass Health's dividend payout ratio (DPR) is presently 15.25%.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on EHC shares. William Blair restated an "outperform" rating on shares of Encompass Health in a report on Friday, February 7th. KeyCorp boosted their price target on Encompass Health from $117.00 to $120.00 and gave the stock an "overweight" rating in a research report on Monday, February 10th. Royal Bank of Canada reissued an "outperform" rating and issued a $110.00 price objective on shares of Encompass Health in a report on Tuesday, February 11th. StockNews.com downgraded shares of Encompass Health from a "buy" rating to a "hold" rating in a report on Thursday, April 3rd. Finally, Barclays increased their price target on shares of Encompass Health from $116.00 to $118.00 and gave the company an "overweight" rating in a research note on Friday, February 7th. One analyst has rated the stock with a hold rating, nine have given a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Buy" and a consensus price target of $107.67.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.